Greg Bydlinski

Greg Bydlinski joined DavosPharma in 2016. He is responsible for business development in Canada while providing technical support in the New England area. Prior to joining DavosPharma, Dr. Bydlinski was a Business Development Manager/R&D Director/R&D Supervisor/Senior Scientist with Delmar Chemicals, Montreal over a period of twenty years. Dr. Bydlinski started his process chemistry career in 1987 at Ciba-Geigy, Summit, NJ. Dr. Bydlinski earned his BA in Chemistry and Psychobiology from Hamilton College, Clinton, NY. Subsequently, he earned his MSc and PhD from Emory University, Atlanta, GA.